Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356(9235):1099–1104. https://doi.org/10.1016/S0140-6736(00)02742-2
Article CAS PubMed Google Scholar
Behr MA, Kaufmann E, Duffin J, Edelstein PH, Ramakrishnan L (2021) Latent tuberculosis: two centuries of confusion. Am J Respir Crit Care Med 204(2):142–148. https://doi.org/10.1164/rccm.202011-4239PP
Article PubMed PubMed Central Google Scholar
Buonsenso D, Delogu G, Perricone C, Grossi R, Careddu A, De MF, Palucci I, Sanguinetti M, Valentini P, Sali M (2020) Accuracy of QuantiFERON-TB Gold Plus Test for diagnosis of Mycobacterium tuberculosis infection in children. J Clin Microbiol 58(6):e00272-20. https://doi.org/10.1128/jcm.00272-20
Article CAS PubMed PubMed Central Google Scholar
Buonsenso D, Seddon JA, Esposito S, Barcellini L (2023) QuantiFERON-TB Gold Plus performance in children: a narrative review. Pediatr Infect Dis J 42(5):e158-165. https://doi.org/10.1097/INF.0000000000003877
Article PubMed PubMed Central Google Scholar
Centers for Disease Control and Prevention (CDC) (2020) Tuberculin Skin Testing Fact Sheet. Available online:https://www.cdc.gov/tb/publications/factsheets/testing/Tuberculin_Skin_Testing_Information_for_Health_Care_Providers.pdf. Accessed 19 Nov 2024
Cohen A, Mathiasen VD, Schön T, Wejse C (2019) The global prevalence of latent tuberculosis: a systematic review and meta-analysis. Eur Respir J 54(3):1900655. https://doi.org/10.1183/13993003.00655-2019
Cole B, Nilsen DM, Will L, Etkind SC, Burgos M, Chorba T (2020) Essential Components of a public health tuberculosis prevention, control, and elimination program: recommendations of the advisory council for the elimination of tuberculosis and the national tuberculosis controllers association. MMWR Recomm Rep 69(7):1–27. https://doi.org/10.15585/mmwr.rr6907a1
Doležalová K, Hadlova P, Ibrahimova M, Golias J, Baca L, Kopecka E, Sukholytka M, Koziar Vasakova M (2024a) Flow cytometry-based method using diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Tuberculosis (Edinb) 147. https://doi.org/10.1016/j.tube.2024.102518
Doležalová K, Koziar Vašáková M, Pohunek P (2024b) New recommendations in the care of pediatric and adolescent patients with tuberculosis. Official opinion of the Children’s Pulmonology Society ÈLS JEP and the Society for Pneumology and Phthisiology ÈLS JEP. Ces slov Pediat 79(Suppl 1):S25–35. https://doi.org/10.55095/CSPediatrie2024/031
European Centre for Disease Prevention and Control (ECDC) (2011) Use of interferon-gamma release assays in support of TB diagnosis. Available online: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/1103_GUI_IGRA.pdf. Accessed 19 Nov 2024
Farhat M, Greenaway C, Pai M, Menzies D (2006) False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis 10(11):1192–1204. https://www.ingentaconnect.com/content/iuatld/ijtld/2006/00000010/00000011/art00003. Accessed 19 Nov 2024
Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, Bergamini BM, D’Amico R, Marchegiano P, Rumpianesi F, Fabbri LM, Richeldi L (2005) Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 172(5):631–635. https://doi.org/10.1164/rccm.200502-196OC
Fox A, Jeffries DJ, Hill PC, Hammond AS, Lugos MD, Jackson-Sillah D, Donkor SA, Owiafe PK, McAdam KP, Brookes RH (2007) ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease. Trans R Soc Trop Med Hyg 101(7):691–698. https://doi.org/10.1016/j.trstmh.2007.03.001
Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den BS, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L et al (2015) Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 46(6):1563–1576. https://doi.org/10.1183/13993003.01245-2015
Article CAS PubMed PubMed Central Google Scholar
Gopalaswamy R, Dusthackeer VN, Kannayan S, Subbian S (2021) Extrapulmonary tuberculosis—an update on the diagnosis, treatment and drug resistance. J Respir 1(2):141–164. https://doi.org/10.3390/jor1020015
Greveson K, Murray C, Toumpanakis C, Epstein O, Hamilton M, Lipman M (2011) Interferon gamma-release assays for detecting latent tuberculosis infection in patients scheduled for anti-TNFalpha therapy. Frontline Gastroenterol 2(1):26–31. https://doi.org/10.1136/fg.2010.000356
Hamada Y, Den BS, Cirillo DM, Penn-Nicholson A, Ruhwald M, Menzies D, Oxlade O, Falzon D, Kanchar A, Korobitsyn A, Zignol M, Matteelli A, Kasaeva T (2021) Framework for the evaluation of new tests for tuberculosis infection. Eur Respir J 58(2):2004078. https://doi.org/10.1183/13993003.04078-2020
Article PubMed PubMed Central Google Scholar
Herrera V, Perry S, Parsonnet J, Banaei N (2011) Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis 52(8):1031–1037. https://doi.org/10.1093/cid/cir068
Article CAS PubMed Google Scholar
Huang CT, Ruan SY, Tsai YJ, Kuo PH, Ku SC, Lee PL, Kuo LC, Hsu CL, Huang CK, Yang CY, Chien YC, Wang JY, Yu CJ (2016) Effects of acute critical illnesses on the performance of interferon-gamma release assay. Sci Rep 6:19972. https://doi.org/10.1038/srep19972
Article CAS PubMed PubMed Central Google Scholar
Infantino M, Tsalouchos A, Russo E, Laudicina S, Grossi V, Lari B, Benucci M, Stacchini L, Amedei A, Casprini P, Villalta D, Dattolo PC, Manfredi M (2022) Assessing T-cell immunity in kidney transplant recipients with absent antibody production after a 3rd dose of the mRNA-1273 vaccine. Int J Mol Sci 23(20):12333. https://doi.org/10.3390/ijms232012333
Article CAS PubMed PubMed Central Google Scholar
Kim WS, Choi JI, Cheon JE, Kim IO, Yeon KM, Lee HJ (2006) Pulmonary tuberculosis in infants: radiographic and CT findings. AJR Am J Roentgenol 187(4):1024–1033. https://doi.org/10.2214/AJR.04.0751
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174. https://doi.org/10.2307/2529310
Article CAS PubMed Google Scholar
Latorre I, de Souza-Galvao M, Ruiz-Manzano J, Lacoma A, Prat C, Altet N, Ausina V, Dominguez J (2010) Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. Eur Respir J 35(2):338–342. https://doi.org/10.1183/09031936.00196608
Article CAS PubMed Google Scholar
Latorre I, Tytarenko N, Díaz S, Zapf D, Grage-Griebenow E, Saschenbrecker S, de Souza-Galvao M, Casas X, Molina I, Forcada N, Santiago J, Stojanovic Z, Domínguez J (2024) Detection of T-cell responses in tuberculosis patients using a new prototype interferon-gamma release assay. ESCMID Global Abstract Book 2024: 34th Congress of the European societey of clinical microbiology and infectious diseases, Barcelona, Spain, 27-30 April 2024. CMI Communications 1(Suppl):100013, Abstract P0640|03042. https://doi.org/10.1016/j.cmicom.2024.100013
Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, Keane J, Lewinsohn DA, Loeffler AM, Mazurek GH, O’Brien RJ, Pai M, Richeldi L, Salfinger M, Shinnick TM et al (2017) Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. Clin Infect Dis 64(2):111–115. https://doi.org/10.1093/cid/ciw778
Lin PL, Flynn JL (2018) The end of the binary era: revisiting the spectrum of tuberculosis. J Immunol 201(9):2541–2548. https://doi.org/10.4049/jimmunol.1800993
Article CAS PubMed Google Scholar
Lin SY, Desmond EP (2014) Molecular diagnosis of tuberculosis and drug resistance. Clin Lab Med 34(2):297–314. https://doi.org/10.1016/j.cll.2014.02.005
Mancuso JD, Mody RM, Olsen CH, Harrison LH, Santosham M, Aronson NE (2017) The long-term effect of Bacille Calmette-Guerin vaccination on tuberculin skin testing: a 55-year follow-up study. Chest 152(2):282–294. https://doi.org/10.1016/j.chest.2017.01.001
Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K (2010) Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 59(RR05):1–25.https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5905a1.htm . Accessed 19 Nov 2024
Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS (2001) Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 286(14):1740–1747. https://doi.org/10.1001/jama.286.14.1740
Article CAS PubMed Google Scholar
Meier NR, Volken T, Geiger M, Heininger U, Tebruegge M, Ritz N (2019) Risk factors for indeterminate interferon-gamma release assay for the diagnosis of tuberculosis in children-a systematic review and meta-analysis. Front Pediatr 7:208. https://doi.org/10.3389/fped.2019.00208
Article PubMed PubMed Central Google Scholar
Metcalfe JZ, Cattamanchi A, McCulloch CE, Lew JD, Ha NP, Graviss EA (2013) Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 187(2):206–211. https://doi.org/10.1164/rccm.201203-0430OC
Article CAS PubMed PubMed Central Google Scholar
Nemes E, Rozot V, Geldenhuys H, Bilek N, Mabwe S, Abrahams D, Makhethe L, Erasmus M, Keyser A, Toefy A, Cloete Y, Ratangee F, Blauenfeldt T, Ruhwald M, Walzl G et al (2017) Optimization and interpretation of serial QuantiFERON testing to measure acquisition of Mycobacterium tuberculosis infection. Am J Respir Crit Care Med 196(5):638–648. https://doi.org/10.1164/rccm.201704-0817OC
Comments (0)